Literature DB >> 17385083

An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue.

Margaret L Opsahl1, Peter G E Kennedy.   

Abstract

Multiple Sclerosis (MS) is an important demyelinating disease of the central nervous system, the aetiology of which may possibly have a viral component at some stage. In this study we investigated the possible involvement in MS of the human herpes virus Epstein Barr Virus (EBV). Utilising both fluorescent and non-fluorescent in situ hybridisation (FISH) techniques, we examined human post mortem tissues obtained from a tissue bank for the presence of immediate early and late viral gene and protein expression in MS patient normal appearing white matter (NAWM), lesional tissue and normal control brain samples. The technique of mRNA FISH showed that many of the tissues were largely degraded and therefore could not provide any evidence of viral gene expression. Some weak scattered signals, however, were seen in mRNA ISH for both lytic and latent gene transcription in all three tissue categories. The failure of IF and mRNA FISH in the majority of samples alongside the poor signal for mRNA ISH precluded any definite conclusions to be made as to the possible ongoing involvement of EBV in MS. While certainly not ruling out a possible role of EBV in MS, especially in the context of a 'hit and run' mechanism, these studies illustrate the difficulties of using autopsy tissues for molecular studies when tissue preservation is sub-optimal. Nevertheless, the limited data obtained did not provide any positive evidence of EBV involvement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17385083     DOI: 10.1007/s00415-006-0316-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Herpesviruses in multiple sclerosis.

Authors:  R M Herndon
Journal:  Arch Neurol       Date:  1996-02

2.  Epstein-Barr virus and disease activity in multiple sclerosis.

Authors:  D Buljevac; G J J van Doornum; H Z Flach; J Groen; A D M E Osterhaus; W Hop; P A van Doorn; F G A van der Meché; R Q Hintzen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

3.  Correlation between HHV-6 reactivation and multiple sclerosis disease activity.

Authors:  Svetlana Chapenko; Andrejs Millers; Zaiga Nora; Inara Logina; Rita Kukaine; Modra Murovska
Journal:  J Med Virol       Date:  2003-01       Impact factor: 2.327

4.  The association of the human herpesvirus-6 and MS.

Authors:  J E Friedman; M J Lyons; G Cu; D V Ablashl; J E Whitman; M Edgar; M Koskiniemi; A Vaheri; J B Zabriskie
Journal:  Mult Scler       Date:  1999-10       Impact factor: 6.312

5.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

Review 6.  Varicella zoster virus latency, neurological disease and experimental models: an update.

Authors:  Randall J Cohrs; Donald H Gilden; Ravi Mahalingam
Journal:  Front Biosci       Date:  2004-01-01

7.  Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

Authors:  Rossana Berti; Meghan B Brennan; Samantha S Soldan; Joan M Ohayon; Luca Casareto; Henry F McFarland; Steven Jacobson
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

8.  Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis.

Authors:  P F Bray; L C Bloomer; V C Salmon; M H Bagley; P D Larsen
Journal:  Arch Neurol       Date:  1983-07

9.  An endogenous retrovirus with nucleic acid sequences similar to those of the multiple sclerosis associated retrovirus at the human T-cell receptor alpha, delta gene locus.

Authors:  P M Alliel; J P Périn; R Pierig; F Rieger
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1998-09       Impact factor: 1.770

Review 10.  HSV LAT and neuronal survival.

Authors:  David C Bloom
Journal:  Int Rev Immunol       Date:  2004 Jan-Apr       Impact factor: 5.311

View more
  11 in total

Review 1.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

2.  Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.

Authors:  S A Sargsyan; A J Shearer; A M Ritchie; M P Burgoon; S Anderson; B Hemmer; C Stadelmann; S Gattenlöhner; G P Owens; D Gilden; J L Bennett
Journal:  Neurology       Date:  2010-03-10       Impact factor: 9.910

Review 3.  Review part 2: Human herpesvirus-6 in central nervous system diseases.

Authors:  Karen Yao; John R Crawford; Anthony L Komaroff; Dharam V Ablashi; Steven Jacobson
Journal:  J Med Virol       Date:  2010-10       Impact factor: 2.327

4.  Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.

Authors:  Simon N Willis; Christine Stadelmann; Scott J Rodig; Tyler Caron; Stefan Gattenloehner; Scott S Mallozzi; Jill E Roughan; Stefany E Almendinger; Megan M Blewett; Wolfgang Brück; David A Hafler; Kevin C O'Connor
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

Review 5.  The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.

Authors:  Caterina Veroni; Francesca Aloisi
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

Review 6.  Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Authors:  Andreas Lossius; Jorunn N Johansen; Øivind Torkildsen; Frode Vartdal; Trygve Holmøy
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

7.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.

Authors:  Barbara Serafini; Barbara Rosicarelli; Diego Franciotta; Roberta Magliozzi; Richard Reynolds; Paola Cinque; Laura Andreoni; Pankaj Trivedi; Marco Salvetti; Alberto Faggioni; Francesca Aloisi
Journal:  J Exp Med       Date:  2007-11-05       Impact factor: 14.307

8.  Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.

Authors:  Asma Hassani; John R Corboy; Suhail Al-Salam; Gulfaraz Khan
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

9.  Molecular signature of Epstein-Barr virus infection in MS brain lesions.

Authors:  Monica A Moreno; Noga Or-Geva; Blake T Aftab; Rajiv Khanna; Ed Croze; Lawrence Steinman; May H Han
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-06-07

Review 10.  Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies.

Authors:  Amit Bar-Or; Michael P Pender; Rajiv Khanna; Lawrence Steinman; Hans-Peter Hartung; Tap Maniar; Ed Croze; Blake T Aftab; Gavin Giovannoni; Manher A Joshi
Journal:  Trends Mol Med       Date:  2019-12-17       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.